1083 / 1456
•
N=25
•
Period: 2004-2006
•
Median age: 26 months
(range, 2,4 months-19,5 years)
•
Multimodality treatment:
(surgery+/-radiation therapy [54 Gy
at 2 Gy/fraction, N=15]+/-chemo)
The objective
response rate
observed after RT was 38%.
The
2-year progression-free and
overall survival
rates are
53%
±
13% and
70%
±
10%,
J Clin Oncol. 2009 January 20; 27(3): 385–389.